8-KCorporate ChangesExhibits & Filings

REGENERON PHARMACEUTICALS, INC. 8-K Report, Bylaw Amendment (Feb 2, 2016)

Filed February 2, 2016For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on February 2, 2016, to report an amendment to its By-Laws, effective January 28, 2016. This amendment implements a majority voting standard for uncontested director elections. Under the new by-laws, a director nominee will be elected if they receive more votes in favor of their election than against it. This change signifies a shift towards greater shareholder influence in board composition, particularly in situations where director nominations are not contested by shareholders. The company noted that director elections would still follow a plurality standard if a shareholder validly nominates a candidate, adhering to advance notice requirements. This development is important for investors as it enhances corporate governance and aligns director accountability more closely with shareholder interests. A majority voting standard in uncontested elections generally means that directors are expected to garner support from a majority of the votes cast, fostering a more responsive board. Investors should note this change as it could influence future board composition and the effectiveness of shareholder engagement on governance matters.

Key Highlights

  • 1Regeneron Pharmaceuticals amended its By-Laws to adopt a majority voting standard for uncontested director elections.
  • 2The amendment, effective January 28, 2016, requires director nominees to receive more votes cast for than against to be elected.
  • 3A plurality voting standard will still apply if a shareholder validly nominates a director candidate.
  • 4This change strengthens corporate governance by increasing director accountability to shareholders.
  • 5The Board of Directors approved the amendment based on the recommendation of the Corporate Governance and Compliance Committee.
  • 6The filing is an 8-K Current Report dated February 2, 2016, reporting an event from January 28, 2016.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce an amendment to Regeneron's By-Laws that implements a majority voting standard for uncontested director elections.

In uncontested director elections, a nominee must receive more votes cast in favor of their election than votes cast against it to be elected to the Board of Directors. Previously, director elections were typically based on a plurality standard.

No, the amendment specifies that the plurality voting standard will continue to apply for director elections if a shareholder validly nominates a candidate in accordance with the By-Laws' advance notice requirements. The majority voting standard applies specifically to uncontested elections.

This change is significant for investors as it enhances corporate governance by making directors more directly accountable to shareholders. A majority voting standard in uncontested elections generally aligns director performance with shareholder expectations and may encourage greater shareholder participation in governance.